These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 10676637
1. Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu. Roh H, Pippin J, Drebin JA. Cancer Res; 2000 Feb 01; 60(3):560-5. PubMed ID: 10676637 [Abstract] [Full Text] [Related]
2. HER2/neu antisense targeting of human breast carcinoma. Roh H, Pippin JA, Green DW, Boswell CB, Hirose CT, Mokadam N, Drebin JA. Oncogene; 2000 Dec 11; 19(53):6138-43. PubMed ID: 11156527 [Abstract] [Full Text] [Related]
3. Antisense oligonucleotides specific for the HER2/neu oncogene inhibit the growth of human breast carcinoma cells that overexpress HER2/neu. Roh H, Pippin J, Boswell C, Drebin JA. J Surg Res; 1998 Jun 11; 77(1):85-90. PubMed ID: 9698539 [Abstract] [Full Text] [Related]
4. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu. Wen CC, Cheng SA, Hsuen SP, Huang YL, Kuo ZK, Lee HF, Kuo CH, Du JL, Wang WB. Cancer Res; 2006 Jun 01; 66(11):5847-57. PubMed ID: 16740724 [Abstract] [Full Text] [Related]
5. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S. J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691 [Abstract] [Full Text] [Related]
6. Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model. Bartholomeusz C, Itamochi H, Yuan LX, Esteva FJ, Wood CG, Terakawa N, Hung MC, Ueno NT. Cancer Res; 2005 Sep 15; 65(18):8406-13. PubMed ID: 16166319 [Abstract] [Full Text] [Related]
7. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P. Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418 [Abstract] [Full Text] [Related]
11. Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells. Rahman KM, Aranha O, Glazyrin A, Chinni SR, Sarkar FH. Oncogene; 2000 Nov 23; 19(50):5764-71. PubMed ID: 11126363 [Abstract] [Full Text] [Related]
12. HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Tuna M, Chavez-Reyes A, Tari AM. Oncogene; 2005 Feb 24; 24(9):1648-52. PubMed ID: 15674342 [Abstract] [Full Text] [Related]
14. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH. Oncogene; 2004 Oct 21; 23(49):8135-45. PubMed ID: 15361828 [Abstract] [Full Text] [Related]
15. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway. Ueno NT, Bartholomeusz C, Herrmann JL, Estrov Z, Shao R, Andreeff M, Price J, Paul RW, Anklesaria P, Yu D, Hung MC. Clin Cancer Res; 2000 Jan 21; 6(1):250-9. PubMed ID: 10656456 [Abstract] [Full Text] [Related]
16. [Effects of Her-2/neu siRNA-mediated gene silencing on cell cycle and apoptosis of lung adenocarcinoma cells]. Ren SH, Wang JW, Zhang L. Zhonghua Yi Xue Za Zhi; 2005 Jun 15; 85(22):1530-4. PubMed ID: 16179111 [Abstract] [Full Text] [Related]